The Cancer Consortium provides a variety of funding opportunities for the purpose of supporting existing members and recruiting new ones, with the ultimate goal of stimulating innovative cancer research. Opportunities include Pilot Awards, New Investigator Awards, and Catchment Area Health Pilot Awards.
Consortium developmental awards are funded through a combination of Cancer Center Support Grant (CCSG) funds and philanthropic donations. Applications for each award are evaluated by a committee of Consortium faculty reviewers.
Eligibility and application requirements are different for each award. For more information, please review the description and RFA for each individual award.
Consortium members automatically receive notice of new funding opportunities. Fred Hutch, University of Washington, and Seattle Children's faculty and staff who are not members can sign up to receive our RFA's.
Cancer Consortium Pilot Award: 2026 Competition Closed
Funds are available from the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium (“The Consortium”) Cancer Center Support Grant (CCSG) and philanthropic funds to support cancer-related pilot projects. This competition will provide awards of up to $100,000 direct costs (plus F&A/indrect costs as allowable) for one year of pilot project support.
Eligibility
- Pilot funding eligibility is restricted to Consortium members and provisional members. For full eligibility criteria, see the Application Process section of the RFA.
- There are no limitations on research topic, provided the problem under study is focused on cancer. Highly innovative concepts that have the potential to improve the lives of cancer patients are encouraged. Also, non-interventional cross-disciplinary research is an area of special interest in this competition.
Important Dates
- Release date: January 5, 2026
- Due date: February 13, 2026
Application Instructions
- Request for Applications - 2026 Cancer Consortium Pilot Awards
- Follow the instructions in the RFA to submit your application via InfoReady.
Contact
New Investigator Award: 2026 Competition Now Open
Funds are available from the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium (“The Consortium”) Cancer Center Support Grant (CCSG) to provide developmental support to assistant and associate professors within the Cancer Consortium. These funds are intended to help investigators generate preliminary data for future cancer-related grant applications and to accelerate their path toward independent research funding. In addition to supporting research, the award is designed to foster career development by encouraging structured mentorship, participation in professional development activities that enhance research leadership skills, and integration into Consortium programs through collaborations with established investigators. This competition will provide two to three awards of up to $100,000 direct costs each (plus F&A/indirect costs).
Eligibility
- Applicants must be Consortium members or provisional members by the application deadline to be eligible. For additional information about membership categories (member, provisional member, and clinical trial affiliate) and an up-to-date listing of Consortium members, visit our website here.
- Assistant and Associate Professor-level faculty who have begun their appointment at one of the Consortium institution's (Fred Hutch, University of Washington, Seattle Children's) on or after July 2023.
- New faculty being recruited who will meet Consortium membership criteria at the time of the award start date (July 1, 2026).
- Consortium members in acting faculty positions are eligible to apply.
Faculty who meet the following criteria are NOT eligible for this award:
- Faculty who have received a CCSG-funded award of any kind OR a pilot award funded by Safeway within three years of the anticipated award start date (July 1, 2026).
- Investigators who are PIs on R01, P01, or P50 grants.
- Faculty with clinical trial affiliate membership are not eligible to apply but can be involved in the project as collaborators.
Faculty can only serve as PI on one new investigator award application per each annual New Investigator Award competition; however, they may be collaborators/co-investigators on more than one application.
Important Dates
- Release date: April 1, 2026
- Due date: May 15, 2026
Application Instructions
- Request for Applications – 2026 New Investigator Awards
- Follow the instructions in the RFA to submit your application via InfoReady.
Contact
Catchment Area Pilot Award: 2026 Competition Now Open
Funds are available from the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium ("the Consortium") Cancer Center Support Grant (CCSG) to support cancer-related projects focused on:
- The Consortium's catchment area, which includes the entire state of Washington. Pilot proposals in the catchment area of Washington must focus on primary research or secondary analysis.
- Populations in the state of Alaska. Pilot proposals in Alaska can include primary research and secondary analyses as well as projects that aim to set up research infrastructure for a future study and/or partnership with Alaska-based organizations, communities, investigators, or healthcare systems.
This competition will provide up to two awards at a maximum of $100,000 in direct costs (plus F&A/indirect costs), for one year. Priority will be given to funding at least one award that focuses on the cancer burden or cancer disparities within Alaska.
Eligibility
Cancer Consortium members at all three Consortium institutions are eligible to apply. Members who have received a Cancer Center Support Grant (CCSG)-funded award of any kind within three years of the anticipated award start date (July 1, 2026) are not eligible to apply. Proposals should not be an extension of on-going, well-established, or recently funded studies. Grants from more established investigators (e.g. Professors) will be competitive if they are for a pilot study that is needed to establish a new direction or research project. Collaborations between established investigators and junior colleagues will also be viewed favorably.
Important Dates
- Release date: March 30, 2026
- Due date: May 18, 2026
Application Instructions
- Request for Applications - 2026 Cancer Consortium Catchment Area Pilot Award
- Follow the instructions in the RFA to submit your application via InfoReady.
Contact
- Kathy Briant kbriant@fredhutch.org or Elizabeth Carosso ecarosso@fredhutch.org
Survivorship Pilot Award: 2026 Competition Opening in Fall
The Survivorship Program invites proposals of high impact and innovation that will promote new research directions focused on cancer survivors. The goal of this award is to stimulate cross-institutional collaborations (Fred Hutch, University of Washington, Seattle Children’s) and/or new collaborations between Consortium investigators who have not previously worked together.
Eligibility
- At least one of the primary investigators should be a Cancer Consortium investigator (https://www.cancerconsortium.org/en/membership.html).
- Priority will be given to applications that center on cross-institutional collaborations (investigators with primary appointments at different Consortium partners) and/or new collaborations (which can be among investigators based at the same Consortium partner but who have no previously co-funded work and no significant non-funded prior collaborations).
- Priority will be given to investigators who have not previously received a Survivorship Pilot award.
- A member of the application team will be asked to pitch their proposal at the Late Effects & Survivorship Seminar on January 9, 2025 (1 to 3pm).
Important Dates
- Due date: December 31, 2024
- Awardees will be announced no later than February 1, 2025.
Application Instructions
Click here to view the full RFA for the Cancer Consortium Survivorship Research Pilot Award.
Submit as a PDF file labeled with your last names and shortened title containing the following information to Emily Artim (erajotte@fredhutch.org):
- Project Title, Investigator Names, Institutional Positions, with brief explanation of how this represents a cross-institutional collaboration and/or new collaboration (if relevant)
- Proposal (limited to 2 pages, NIH formatting rules), including as appropriate: Background (i.e., significance/innovation), Aims and Hypotheses, Approach (any preliminary data [not required], study design, statistical considerations [highly encouraged]), and Future Plans (i.e., how will this award lead to new grants)
- Any tables and figures (limited to 1 additional page)
- References (limited to 1 additional page)
- Investigator biosketches (NIH format)
Contact
- Dr. Eric Chow, Co-Director of the Fred Hutch Survivorship Program at ericchow@uw.edu
Trainee Travel Award: 2026 Competition Closed
The Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium Trainee Travel Award is available to postdoctoral fellows, graduate students, and medical fellows whose faculty advisor is a member of the Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium. Faculty members can be found on the Cancer Consortium website. The scholarship can be applied to registration, travel, and accommodation costs for any conference that will further their professional development. The award is for up to $1,500 or the cost of the conference, whichever is less. Expenses and travel for these awards MUST be completed and paid by May 29, 2026.
Important Dates
- Application Deadline: January 30, 2026
Application Instructions
There are multiple possible awards and eligibility for the various awards based on your position/title and institution. In addition to providing information about your conference, you will be asked the following:
- Provide a statement outlining how taking this conference will help you achieve your current and/or future career goals.
- If you are asking for more than $500, you will need a PI or faculty advisor to submit a letter of recommendation, identify another reference, or provide an explanation if you will not have a reference.
- Provide an abstract if you intend to present a talk or a poster at a conference. Due to the current travel restrictions, presenting commitments are required.
You can find the application here: Apply Now
Contact
- KC Cruz at kcruz@fredhutch.org
CCSG Administrative Supplements
NCI periodically announces administrative supplement opportunities. If and when the CCSG P30 is an eligible parent grant for an opportunity, Consortium members are notified. Any active opportunities are listed below.
The National Cancer Institute’s Division of Cancer Control & Population Sciences has announced twenty-six administrative supplement funding opportunities. The full RFA and descriptions of each opportunity can be found here: https://cancercontrol.cancer.gov/funding/dccps-topics-of-interest-for-administrative-supplements-in-fy26.
Important Application Details
Application Deadline: NCI will accept proposals on a rolling basis through July 31, 2026. Requests submitted after this date will not be considered. Investigators are strongly encouraged to apply early to maximize the likelihood of receiving FY26 funds.
Parent Grant Eligibility: The following NCI-funded mechanisms qualify as eligible parent grants: R01, R37, R00, P01, P30, P50, U01, UM1, UH3, U54, and U19. The parent grant must be active and have at least one year of support remaining. Due to the volume of supplement opportunities available and limit of one supplement application per parent award per topic, applicants are strongly encouraged to apply using their own eligible grant or that of a colleague. If you are interested in pursuing one of these opportunities but do not have access to an eligible parent grant, you may have the option to apply under the Cancer Center Support Grant (CCSG) P30; however, Consortium Administration is only able to support a limited number of applications.
Utilizing the CCSG as the Parent Grant:
If you are interested in submitting a supplement application using the CCSG as the parent grant, please upload a one-age letter of intent (LOI) using the below template through the Smartsheet form no later than COB Tuesday, April 7. The LOI must include the supplement topic of interest to which you want to apply, and the anticipated timeframe for finalizing your application materials. You will be notified by April 17 about next steps.
- DCCPS Administrative Supplement FY26 CCSG LOI Template
- DCCPS Administrative Supplement FY26 CCSG Form
Please note, if multiple Consortium members express interest in applying for the same opportunity, Consortium leadership will determine which applicant(s) may proceed. Further, Consortium Administration is only able to support 2-3 supplement applications each month from May through July. If the number of LOIs received exceeds the number of applications we can accommodate, Consortium leadership will determine the order of submissions. However, please keep in mind that your submission deadline may not align with your proposed timeline.
Budget: The budget should not exceed $100,000 in total costs.
Application Requirements: The application must include the following sections and adhere to the following limits:
- Project Summary/Abstract: 30 lines of text
- Project Narrative: 3 sentences
- Research Strategy: 5 pages
- Biographical Sketch: for Senior/Key Personnel and Significant Contributors only
If you have any general questions about these funding opportunities or the LOI process, please contact cancerconsortium@fredhutch.org.
Pilot Award
- Kevin Barry, PhD | Cancer Immunology | Fred Hutch
- Nicole Dussault, MD, MS | Cancer Epidemiology, Prevention & Control | Fred Hutch
- Stanley Lee, PhD | Hematologic Malignancies | Fred Hutch
- Jamie Takayesu, MD | Prostate Cancer | UW
- Raymond Yeung, MD | Non-Programatically Aligned | UW
- Steven Henikoff, PhD | Cancer Basic Biology | Fred Hutch
- Shachi Mittal, PhD | Breast & Ovary Cancers | UW
Pilot Award
- Hiba Khan, MD+ | Prostate Cancer | UW
- Alexander Mendenhall, PhD^ | Cancer Basic Biology | UW
- Yasemin Sancak, PhD | Cancer Basic Biology | UW
- Parth Shah, PharmD, PhD | Cancer Epidemiology, Prevention & Control | Fred Hutch
+ Catchment Area Pilot; ^ Cross Disciplinary
New Investigator Award
- Yasuhiro Arimura, PhD | Cancer Basic Biology | Fred Hutch
- Nicholas Riley, PhD | Cancer Basic Biology | Fred Hutch
- Kamen Simeonov, PhD | Cancer Basic Biology | Fred Hutch
- Autumn York, PhD | Cancer Immunology | UW
Survivorship Award
- Paul Carpenter, MD | Hematologic Malignancies | Fred Hutch
- Stacey Cohen, MD | Non-Programatically Aligned | UW
- Rachel Issaka, MD, MAS | Cancer Epidemiology, Prevention & Control | Fred Hutch
- Stephanie Lee, MD, MPH | Hematologic Malignancies | Fred Hutch
- Veena Shankaran, MD | Cancer Epidemiology, Prevention & Control | Fred Hutch
- Megan Shen, PhD | Cancer Epidemiology, Prevention & Control | Fred Hutch